Onward Medical N.V. announced the appointment of Kristina Dziekan to its Board of Directors. Ms. Dziekan is currently Head of Market Access, Government Affairs, and Tendering for Alcon's Surgical Division in Europe. She previously served as Senior Global Reimbursement and Health Economics Director for Medtronic Neuromodulation and was also Health Outcomes Manager for GlaxoSmithKline in the UK and parts of Asia.

She earned an MSc in Health Policy, Planning, and Financing from the London School of Economics, an MA in International Economics and European Studies from Johns Hopkins University, a BA in Philosophy, Politics, and Economics from Oxford University, and a Vordiplom in Business Administration and Economics from Georg August University. Ms. Dziekan was appointed to a four-year term during ONWARD's Annual General Meeting, held 10 June 2022 in Amsterdam, the Netherlands.